Bastion Asset Management Inc. Neogenomics Inc Transaction History
Bastion Asset Management Inc.
- $213 Billion
- Q2 2025
A detailed history of Bastion Asset Management Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Bastion Asset Management Inc. holds 187,536 shares of NEO stock, worth $1.08 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
187,536Holding current value
$1.08 Million% of portfolio
0.66%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
283Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$113 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$82.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$38.7 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$34.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$33.1 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $725M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...